Trillium Therapeutics Inc. T.TRIL

Healthcare Biotechnology

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.

TSX:TRIL - Post by User

Trillium Therapeutics Inc.

Bullboard Posts

Post by Thereson May 15, 2009 10:51am

338 Views

Post# 15995823

10:45:55

Long episode without sell or almost none of buyers

STEM CELL THERAPEUTICS CORP				10:45:55 AM HAE
Symbole	T	Acheteur	Vendeur	Dernier	Variation	Volume	ISF
SSS CA V	+	0,10	0,105	0,10	-0,015	8 606 927

Taille acheteur		51		Taille vendeur		999
Haut du jour		0,115		Bas du jour		0,095
Ouverture		0,115

than

price falling

STEM CELL THERAPEUTICS CORP				10:48:46 AM HAE
Symbole	T	Acheteur	Vendeur	Dernier	Variation	Volume	ISF
SSS CA V	-	0,095	0,10	0,10	-0,015	8 632 427

Taille acheteur		999		Taille vendeur		81
Haut du jour		0,115		Bas du jour		0,095
Ouverture		0,115